Strategies for Optimizing the Diagnostic Predictive Value of Clostridium difficile Molecular Diagnostics

Area of Science:

• Clinical microbiology
• Infectious diseases
• Diagnostic testing

Background:

• Nucleic acid amplification tests (NAATs) for Clostridium difficile infection (CDI) cannot differentiate between active infection and asymptomatic carriage.
• This limitation reduces the diagnostic predictive value of NAATs, particularly in patients with a low probability of CDI.

Purpose of the Study:

• To evaluate the impact of a novel intervention aimed at optimizing the use of NAATs for CDI detection.
• To reduce unnecessary testing and subsequent treatment for Clostridium difficile.

Main Methods:

• Implementation of a clinical bioinformatics-driven intervention to prevent inappropriate stool testing for C. difficile.
• Targeting patients without clinically significant diarrhea and those with recent laxative use for testing restrictions.

Main Results:

• Significant reductions in hospital-onset CDI were observed after the intervention's implementation.
• A notable decrease in the utilization of oral vancomycin was reported at the institution.

Conclusions:

• Optimizing diagnostic testing strategies, particularly for NAATs in CDI, can lead to improved patient outcomes.
• Leveraging clinical bioinformatics resources can effectively reduce unnecessary testing and antimicrobial use, thereby combating hospital-acquired infections.